- Home
- RIOT vs LEGN Comparison
RIOT vs LEGN Comparison
Compare RIOT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIOT | LEGN |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.9B |
| IPO Year | 2002 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RIOT | LEGN |
|---|---|---|
| Price | $16.90 | $18.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | $25.81 | ★ $63.08 |
| AVG Volume (30 Days) | ★ 15.2M | 1.2M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $647,435,000.00 | N/A |
| Revenue This Year | N/A | $42.19 |
| Revenue Next Year | $23.45 | $33.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 71.89 | N/A |
| 52 Week Low | $6.19 | $16.24 |
| 52 Week High | $23.94 | $45.30 |
Technical Indicators
Market Signals| Indicator | RIOT | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 63.17 | 52.31 |
| Support Level | $16.43 | $16.47 |
| Resistance Level | $17.41 | $20.39 |
| Average True Range (ATR) | 1.00 | 0.78 |
| MACD | 0.38 | 0.12 |
| Stochastic Oscillator | 93.66 | 71.80 |
Price Performance
Historical ComparisonAbout RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.